AGP Executive Report
Last update: an hour agoCannabis Policy & Regulation: A new federal law is pushing Oregon CBD retailers to shut down most hemp-derived pet tinctures and topicals, while dispensaries selling marijuana products can stay open—highlighting how quickly rules can reshape the CBD shelf. Federal Oversight: A GAO report says U.S. drug scheduling decisions by the DEA and FDA can be “arbitrary,” with the DEA lacking clear internal policies for how staff evaluate and schedule substances—fueling fresh criticism of the rescheduling process. Market Access (EU): Europe’s CBD outlook gets a boost after EFSA issued its first positive CBD opinion, but the piece stresses approvals and strict intake limits still make a fast market boom unlikely. Insurance & Banking: Michigan and Ohio cannabis operators got a potential win as insurers back the bipartisan CLAIM Act, aiming to shield insurers from federal penalties tied to state-legal marijuana coverage. Medical Cannabis: Pennsylvania lawmakers advanced a bill to let terminally ill patients use medical marijuana in hospitals and long-term care (no smoking/vaping; locked storage; facility guidelines). Local Reform: Washington’s Pierce County voted to make entheogen-related activities a low-priority enforcement matter when no other violations are present. Data & Consumer Trust: Metrc-backed research finds state-issued cannabis QR codes boost consumer trust and may pull buyers toward legal products.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
